Xtherapeutics ApS: Financial statements 2021
CVR: 37384089
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
Xtherapeutics ApS (CVR 37384089) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -5,151 compared with DKK 0 the year before. Equity in the 2021 report amounted to DKK -12,650.
- Profit/Loss
- DKK -5,151
- Equity
- DKK -12,650
- Total Assets
- DKK 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -5 t. | -13 t. | - |
| 2020 | 0 | 0 | 0 | 1 | - |
| 2019 | 0 | 0 | 0 | 1 | - |
| 2018 | - | - | -8 t. | -7 t. | - |
Official annual report
Find more companies like Xtherapeutics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
On October 12, 2021, the company changed its name from Xtherapeutics IVS to Xtherapeutics ApS.
About Xtherapeutics ApS
Xtherapeutics ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2016. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Xtherapeutics IVS and Vaccex IVS. The management consists of Thomas Lars Andresen. The company is owned by Jonas Rosager Henriksen, Anders Elias Hansen and TLA-HOLDING 2010 ApS. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -14,323 the year before. Equity in the 2025 report amounted to DKK -18,439.